FindTrial
Sign In

Study on effect and mechanism of Lactobacillus on in patients with respiratory allergy

Study on effect and mechanism of Lactobacillus (CCFM1040) on in patients with respiratory allergy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024200
Enrollment
Unknown
Registered
2019-06-30
Start date
2019-07-05
Completion date
Unknown
Last updated
2019-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma and allergic rhinitis

Interventions

Placebo asthma group:Placebo
lactobacillus CCFM1040 asthma group:lactobacillus CCFM1040
lactobacillusCCFM1040 allergic rhinitis group:lactobacillusCCFM1040

Sponsors

The Peoples' Hospital of Tinghu District of Yancheng City
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of asthma and allergic rhinitis; 2. Aged 6 to 40 years, male or female; 3. Compliance with the requirements of clinical trials; 4. Blood, urine, stool, liver and kidney function were all in the normal range.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Short-term or long-term use of antibiotics; 3. Accompanied by diabetes, cardiovascular, history of malignant disease; 4. Enteritis, etc.; 5. Accompanied by mental illness.

Design outcomes

Primary

MeasureTime frame
Height;Weight;Fecal flora;Blood routine;Urine routine;liver function;Blood lipid level;Fecal routine;All Blood Cells Analysis;—

Countries

China

Contacts

Public ContactWenwei Lu

Jiangnan University

luwenwei@jiangnan.edu.cn+86 18762691080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026